Table 1. Patient characteristics and primary treatment of brain metastases.
KPS: Karnofsky performance status, NSCLC: non-small cell lung cancer, WBRT: whole-brain radiotherapy, SRS: stereotactic radiosurgery, RT: radiotherapy
| Short interval <36 months | Interval at least 36 months | |
| Median age (years), range | 65, 28-90 | 74, 56-83 |
| Median number of metastases | 1, 1-4 | 1, 1-4 |
| Median KPS | 80, 50-100 | 80, 70-90 |
| Female gender | 38 (46%) | 7 (100%) |
| NSCLC | 51 (62%) | 1 (14%) |
| Breast cancer | 4 (5%) | 2 (29%) |
| Malignant melanoma | 4 (5%) | 2 (29%) |
| Kidney cancer | 4 (5%) | 1 (14%) |
| Colorectal cancer | 6 (7%) | 1 (14%) |
| Others | 13 (16%) | 0 |
| Neurosurgical resection | 32 (39%) | 5 (71%) |
| Primary WBRT | 31 (38%) | 0 |
| SRS and other RT | 19 (23%) | 2 (29%) |